Jan Greene

Claire McAndrew

Narrow networks mean lower premiums. Now, state insurance commissioners are wrestling with how they should be regulated so that insurers stay solvent and consumers are protected.

Original Research
Kathryn Fitch, RN, MEd
Tyler Engel, ASA, MAAA
Andrew Bochner, ASA, MAAA
Legislation & Regulation
Richard Mark Kirkner

Dick Woodruff

The NIH would get a $9 billion shot in the arm, but some fear the FDA provisions will mean lax oversight of drugs and devices.

Tomorrow's Medicine
Thomas Morrow, MD

Brace yourself for astronomically priced injections. One on track for U.S. approval looks to treat a rare form of retinal disease.

News & Commentary